Equities research analysts forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report sales of $717.00 million for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for Acadia Healthcare’s earnings, with the lowest sales estimate coming in at $708.91 million and the highest estimate coming in at $722.58 million. Acadia Healthcare reported sales of $756.55 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 5.2%. The firm is scheduled to announce its next earnings results after the market closes on Thursday, July 27th.

According to Zacks, analysts expect that Acadia Healthcare will report full-year sales of $717.00 million for the current fiscal year, with estimates ranging from $2.85 billion to $2.89 billion. For the next financial year, analysts anticipate that the company will report sales of $3.09 billion per share, with estimates ranging from $3.04 billion to $3.13 billion. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.46. The firm had revenue of $679.20 million for the quarter, compared to analyst estimates of $691.74 million. Acadia Healthcare had a net margin of 0.53% and a return on equity of 8.89%. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.55 earnings per share.

ACHC has been the topic of a number of recent research reports. Deutsche Bank AG initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 5th. They issued a “buy” rating and a $53.00 target price on the stock. Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Friday, March 24th. Jefferies Group LLC set a $55.00 target price on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Thursday, June 1st. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $45.00 target price on shares of Acadia Healthcare in a report on Friday, March 24th. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and an average target price of $57.23.

In other news, COO Ronald Morgan Fincher sold 86,483 shares of the company’s stock in a transaction on Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the transaction, the chief operating officer now directly owns 137,204 shares of the company’s stock, valued at approximately $6,095,973.72. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Randall P. Goldberg sold 4,925 shares of the company’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $45.18, for a total transaction of $222,511.50. Following the transaction, the vice president now directly owns 10,607 shares in the company, valued at $479,224.26. The disclosure for this sale can be found here. Insiders sold a total of 968,102 shares of company stock worth $44,283,109 over the last three months. 11.10% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the company. State Street Corp boosted its position in Acadia Healthcare by 2.6% in the fourth quarter. State Street Corp now owns 1,019,537 shares of the company’s stock worth $33,768,000 after buying an additional 26,282 shares during the period. Dimensional Fund Advisors LP boosted its position in Acadia Healthcare by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 609,118 shares of the company’s stock worth $20,165,000 after buying an additional 8,635 shares during the period. FMR LLC boosted its position in Acadia Healthcare by 223.5% in the fourth quarter. FMR LLC now owns 803,450 shares of the company’s stock worth $26,594,000 after buying an additional 555,106 shares during the period. Guggenheim Capital LLC boosted its position in Acadia Healthcare by 637.2% in the fourth quarter. Guggenheim Capital LLC now owns 43,088 shares of the company’s stock worth $1,426,000 after buying an additional 37,243 shares during the period. Finally, Norges Bank bought a new position in Acadia Healthcare during the fourth quarter worth $8,410,000.

Acadia Healthcare (NASDAQ ACHC) traded down 0.02% during mid-day trading on Friday, hitting $50.89. 695,527 shares of the stock were exchanged. Acadia Healthcare has a 52-week low of $32.54 and a 52-week high of $57.29. The company has a 50 day moving average price of $47.24 and a 200 day moving average price of $43.11. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of 295.87 and a beta of 1.14.

WARNING: This piece was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/07/21/brokerages-expect-acadia-healthcare-company-inc-achc-will-post-quarterly-sales-of-717-00-million.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.